BIOAVAILABILITY DETERMINATION OF 2 CRYSTAL FORMS OF SULFAMETER IN HUMANS FROM URINARY-EXCRETION DATA

被引：14

作者：

KHALAFALLAH, N ^{[1
]}

KHALIL, SA ^{[1
]}

MOUSTAFA, MA ^{[1
]}

机构：

[1] UNIV ALEXANDRIA, FAC PHARM, DEPT PHARM, ALEXANDRIA, U A R

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1974年 / 63卷 / 06期

关键词：

D O I：

10.1002/jps.2600630611

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：861 / 864

页数：4

共 25 条

[1]

BARR WH, 1972, CLIN PHARMACOL THER, V13, P97

[2]

Bratton AC, 1939, J BIOL CHEM, V128, P537

[3]

BRATTON AC, 1939, J PHARMACOL, V67, P454

[4] THE RELATION BETWEEN INVITRO DISINTEGRATION TIME OF SUGAR-COATED TABLETS AND PHYSIOLOGICAL AVAILABILITY OF RIBOFLAVIN [J].

CHAPMAN, DG ;

CRISAFIO, R ;

CAMPBELL, JA .

JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION-SCIENTIFIC EDITION, 1954, 43 (05) :297-304

[5] DIRECT PROPORTIONALITY OF URINARY EXCRETION RATE AND SERUM LEVEL OF TETRACYCLINE IN HUMAN SUBJECTS [J].

CHULSKI, T ;

JOHNSON, RH ;

WAGNER, JG ;

SCHLAGEL, CA .

NATURE, 1963, 198 (487) :450-&

[6] EFFECT OF ADDITIVES ON KINETICS OF INTERCONVERSION OF SULFAMETHOXYDIAZINE CRYSTAL FORMS [J].

EBIAN, AR ;

MOUSTAFA, MA ;

KHALIL, SA ;

MOTAWI, MM .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (01) :13-20

[7]

GLAZKO ANTHONY J., 1958, ANTIBIOT AND CHEMOTHER, V8, P516

[8]

HILLER A, 1957, PRACTICAL CLINICAL C

[9] PHARMACOKINETIC PROFILE OF SULFISOXAZOLE FOLLOWING INTRAVENOUS, INTRAMUSCULAR, AND ORAL ADMINISTRATION TO MAN [J].

KAPLAN, SA ;

WEINFELD, RE ;

ABRUZZO, CW ;

LEWIS, M .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (05) :773-&

[10] GI ABSORPTION OF 2 CRYSTAL FORMS OF SULFAMETER IN MAN [J].

KHALIL, SA ;

EBIAN, AR ;

MOUSTAFA, MA ;

MOTAWI, MM .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (10) :1615-+

← 1 2 3 →